Literature DB >> 9536271

Gene-directed enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB1954 in cells expressing bacterial nitroreductase.

F Friedlos1, S Court, M Ford, W A Denny, C Springer.   

Abstract

Clones of human colon carcinoma (WiDr), ovarian carcinoma (SK-OV-3), and Chinese hamster V79 cells expressing the nitroreductase enzyme (NR) from E. coli B were 52-, 225- and 177-fold respectively more sensitive to a 24-h incubation with the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) than the parent lines. The IC50s of non-NR-expressing bystander cells were measured in the presence of differing proportions of NR-expressing cells. The shift in IC50 was used to calculate a value for the bystander effect, termed the transmission efficiency (TE), which is the decrease in IC50 due to bystander effect as a percentage of the maximum decrease possible. The percentage of NR-expressing cells for which the TE was 50%, (the TE50) is a single datum of bystander efficacy. WiDr and V79 cell lines, had a similar TE50 of approximately 2%. SK-OV-3 gave a lower value of 0.3%. These TE50 correlate with concentrations of cytosolic NR activity, which is distinguished from endogenous DT diaphorase activity by kinetic differences. A novel method is described which enables both DNA crosslinks and drug-induced single-strand breaks to be simultaneously quantified in a sedimentation assay. Using this technique, bystander DNA damage was demonstrated in V79 cells, of approximately 50% of that in activator cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536271     DOI: 10.1038/sj.gt.3300569

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

Review 1.  Prodrug-activating systems in suicide gene therapy.

Authors:  C J Springer; I Niculescu-Duvaz
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

3.  Japanese spousal smoking study revisited: how a tobacco industry funded paper reached erroneous conclusions.

Authors:  E Yano
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

4.  Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.

Authors:  Toru Shibata; Amato J Giaccia; J Martin Brown
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

5.  Enhanced cell-specific ablation in zebrafish using a triple mutant of Escherichia coli nitroreductase.

Authors:  Jonathan R Mathias; Zhanying Zhang; Meera T Saxena; Jeff S Mumm
Journal:  Zebrafish       Date:  2014-01-15       Impact factor: 1.985

Review 6.  Prodrug/drug sensitivity gene therapy: current status.

Authors:  W R Smythe
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.945

7.  Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy).

Authors:  William A. Denny
Journal:  J Biomed Biotechnol       Date:  2003

8.  2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.

Authors:  N A Helsby; D M Ferry; A V Patterson; S M Pullen; W R Wilson
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

9.  An overview of targeted cancer therapy.

Authors:  Viswanadha Vijaya Padma
Journal:  Biomedicine (Taipei)       Date:  2015-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.